Therefore, exploring the molecular machinery involved in adiponectin–betatrophin interactions under insulin resistance could prove extremely valuable both academically and clinically in T2D prevention, diagnosis, and treatment. The gene discussed is ADIPOQ; the disease is Insulin resistance.